← Open Payments lookup

RIFFAT QURESHI: Open Payments

NPI 1134114416 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,104 in 48 payments from 13 companies in 2025. Trend: 2023 $544 · 2024 $850 · 2025 $1,104

Food & beverage: $1,104
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.8$264
ABBVIE INC.12$201
Otsuka America Pharmaceutical, Inc.7$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$77
E.R. Squibb & Sons, L.L.C.4$75
Neurocrine BioSciences, Inc.3$70
Lundbeck LLC3$66
Bausch Health US, LLC3$54
Corium, LLC1$34
Alkermes, Inc.1$30

Products named: VRAYLAR, FANAPT, REXULTI, HETLIOZ, ABILIFY ASIMTUFII, CAPLYTA, COBENFY, INGREZZA.

Industry payments across FL — which companies pay providers there.